Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Multinational Registry to Determine Management and Quality of Care of Patients With Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases

NCT03549754 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03549754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03549754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Multinational Registry to Determine Management and Quality of Care of Patients With Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
February 17, 2018
Completion date
December 31, 2030
Enrollment
35,000 (estimated)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, heart failure, hypertension, type 2 diabetes